Sanxin Medical: Since the strategic layout of the entire industry chain in 2018, the company has achieved a compound annual growth rate of 55.9% in net profit attributable to shareholders of listed companies _ Oriental Fortune Net


Full Data

?
UNLOCK DATA

Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login




Related Data